Quality & Testing

Our analytical standards, explained — and how to verify them for your batch.

At Peptidology, quality isn't a marketing claim — it's an engineering discipline. Every batch we release is built around an analytical program designed to confirm identity, purity, potency, and sterility before a single vial ships. This page explains what we test, why we test it, and how to verify the results for the exact batch you receive.

We're also in the middle of an upgrade. We built our reputation on a 7-point analytical protocol (7x) that already went well beyond the two to three tests typical of the research-chemical industry. We're now extending an expanded 14-point protocol (14x) across our catalog — and more than half of our eligible products have already completed the full 14x panel, with the remainder following batch by batch. The Certificate of Analysis (COA) on every product shows precisely which tests were run on that lot, so you're never left guessing about what your specific batch received.

More than 50% of eligible products now carry our full 14x analytical panel — up from our legacy 7x protocol, and expanding across the catalog. Whichever protocol a batch is tested under, every test must pass, and each batch's COA documents exactly what was performed.

From 7x to 14x: where we are today

For years, our standard was a 7-point analytical protocol — already several times deeper than the two to three tests most research-chemical suppliers run, if they test at all. We're now rolling out a 14-point protocol that roughly doubles the depth of analysis, spanning chromatographic purity and net peptide content, elemental-impurity and endotoxin screening, two independent sterility methods, residual-solvent and residual-TFA analysis, container-closure integrity, and solubility.

Rather than flipping a switch overnight, we're qualifying the 14x panel across the catalog batch by batch. As of today, more than half of our eligible products have completed the full 14x panel. The rule is the same under either protocol: every test in the panel must pass. If any single test fails, the entire batch is rejected.

How to know what your batch received. Every product vial carries a unique, batch-coded QR code that links to that lot's Certificate of Analysis, listing the exact tests performed and their results. If you ever want to confirm the scope or results for a specific batch, the COA is the source of truth — and our team is glad to walk you through it.

Where we source our raw materials

We source raw materials from registered, inspected facilities that manufacture under cGMP-aligned quality systems. Our current supplier network spans the United States and Taiwan.

Rather than relying on a single country of origin, we deliberately diversify our supply chain. This lets us manage risk from regulatory changes, price volatility, and availability disruptions without compromising quality. We evaluate every supplier on its compliance record, audit history, and analytical data — not geography alone — and we monitor our suppliers' regulatory inspection records, acting on any adverse findings.

The 14x analytical panel, in detail

Our full 14x panel is performed across two independent, U.S.-based analytical laboratories — Vanguard Laboratory (Olympia, WA) and Eagle Analytical Services (Houston, TX). For products carrying the 14x panel, we test up to 27 finished-product vials per batch, pulled at random. Here's what the panel covers and why it matters.

1. Chromatographic Purity (HPLC-UV/Vis)

Measures overall peptide purity by high-performance liquid chromatography. Finished products are held to greater than 99% purity; raw materials to greater than 99.5%. This confirms the product is what it claims to be, with minimal degradation or impurities. Tested across 3 vials per batch.

2 & 3. Net Peptide Content / Assay (HPLC-UV/Vis)

Each active peptide is independently assayed to verify the labeled amount. For combination products, every peptide is measured separately — for example, both CJC-1295 and Ipamorelin are individually quantified across 3 vials — so you receive the exact net peptide content stated on the label.

4. Elemental Impurities / Heavy Metals (ICP-MS)

We screen for five elemental impurities by inductively coupled plasma mass spectrometry, one of the most sensitive methods available, and evaluate results against USP <232> acceptance criteria: chromium (LOQ 0.05 ppm), arsenic (0.01 ppm), cadmium (0.01 ppm), lead (0.02 ppm), and mercury (0.005 ppm). All results must fall within the USP <232> limits.

5. Bacterial Endotoxin (LAL Method)

Endotoxins are pyrogenic byproducts of bacterial cell walls. We test 2 vials per batch using the LAL (Limulus Amebocyte Lysate) method against the USP/FDA threshold of less than 5 EU/kg. Every vial must pass.

6. Sterility — USP <71> (Vanguard Laboratory)

The gold-standard compendial sterility test. Five vials per batch are incubated and observed for microbial growth per USP <71>, using the full 14-day incubation protocol — we don't cut corners with shorter methods. Every vial must return "Pass — No Growth."

7. Sterility — ScanRDI Rapid Method (Eagle Analytical)

In addition to the USP <71> test at Vanguard, up to 4 separate vials per batch go to Eagle Analytical Services for independent rapid sterility confirmation by the ScanRDI method. This gives two-lab, two-method sterility verification, with up to 9 vials tested for sterility alone.

8. Residual Solvents (GC-MS)

Peptide synthesis uses chemical solvents that must be fully removed from the finished product. We screen for 16 individual residual solvents by gas chromatography-mass spectrometry, including benzene (LOQ 0.02 ppm), chloroform (0.02 ppm), and dichloromethane (0.45 ppm), plus methanol, ethanol, acetone, hexanes, toluene, and others. All 16 must return Non-Detect.

9. Container-Closure Integrity (Dye Ingress)

A sterile product is only sterile if the seal holds. We test 2 vials per batch by the dye-ingress method to confirm the crimp seal, stopper, and glass vial form an airtight barrier that no external contaminant can breach over the product's shelf life.

10. Solubility Analysis

Each lyophilized (freeze-dried) peptide must fully reconstitute. We verify that 2 vials per batch achieve full solubility in 2 mL of water with no visible particulates, clumping, or incomplete dissolution. If it doesn't dissolve cleanly, the batch doesn't ship.

11. Residual TFA (Ion Chromatography)

Trifluoroacetic acid is a common counterion used during peptide synthesis. We confirm TFA content is Non-Detect at less than 0.10% using ion chromatography.

Within the 14x panel, a failure on any single test rejects the entire batch.

Our testing laboratories

All 14x testing is performed by two independent, U.S.-based analytical laboratories.

Vanguard Laboratory — Olympia, WA. ISO/IEC 17025:2017 accredited (A2LA Certificate #6377.01.01). Performs the full analytical panel: purity, net peptide content, elemental impurities, endotoxins, sterility (USP <71>), residual solvents, container-closure integrity, solubility, and residual TFA.

Eagle Analytical Services — Houston, TX. Provides independent sterility confirmation via the ScanRDI rapid method — our second-lab verification, so no single point of failure exists in sterility testing.

Splitting work across two laboratories means a single lab's error can't pass undetected. If one lab's sterility result disagrees with the other's, the batch is rejected.

What this costs — and the time it adds

Quality at this depth isn't cheap or fast. Running the full 14x panel costs more than $3,000 per batch, and our analytical-testing spend averages about $59,000 per month — not counting the cost of destroyed product samples or the dedicated staff who manage the testing pipeline. That's well above what's typical in this category.

Testing also adds meaningful lead time. The full 14x panel can take up to 45 days to complete, compared with the roughly two-day turnaround many suppliers accept. We believe the wait is worth it.

Manufacturing & finished products

Our finished products are manufactured in GMP-aligned facilities in the United States and Taiwan using aseptic processing. Products pass through a 0.22 µm sterile PES membrane filter before lyophilization (freeze-drying) to support sterility at the point of fill. Every finished vial carries a unique, batch-coded QR code linking to that batch's Certificate of Analysis — including results and expiration date — so any product can be verified in seconds.

Verify any batch: the COA Manager

Testing only matters if you can check the results yourself. That's what the COA Manager is for. Every batch we release carries its own lot-specific Certificate of Analysis, and the COA Manager puts the full library at your fingertips.

Scan the batch-coded QR code on any vial to open that lot's certificate in seconds. Or sign in to the COA Manager to search the entire library by compound or by lot number, pull current and past certificates on demand, and see how purity has held across batches over time — so you're not taking a single number on faith, you're seeing the track record.

Each certificate shows the published results for that exact lot: chromatographic purity, net peptide content and identity, sterility (USP <71> and ScanRDI), endotoxin, and the test and release dates. Nothing is summarized away — the numbers you compare are the numbers we released against.

Browse it anytime at the COA Manager. If you ever can't find the certificate for a batch you received, our team can pull it for you directly.

Our standard vs. the industry

The comparison below reflects our complete 14x panel. The COA on each product shows the exact tests performed on that specific batch.

The bottom line

We built the 14x protocol because researchers shouldn't have to take quality on faith. It's slower and more expensive, and it means we reject batches some suppliers would happily sell. We're proud that more than half of our eligible products already carry the full 14x panel, and we're extending it across the catalog. Every batch's results live on its Certificate of Analysis — scan the QR code on your product, or reach our team and we'll walk you through them.

For Research Use Only

All polypeptide sequences, amino acid derivatives, and analogs sold by Peptidology are strictly for Research Use Only and are not intended for human or veterinary use. Peptidology is a specialized chemical supplier and does not operate as a compounding pharmacy or outsourcing facility under Section 503A or 503B of the Federal Food, Drug, and Cosmetic Act.

Updated on: 21/06/2026